These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32829908)

  • 1. Utility of HAS-BLED and CHA
    Ward R; Ponamgi S; DeSimone CV; English S; Hodge DO; Slusser JP; Graff-Radford J; Rabinstein AA; Asirvatham SJ; Holmes D
    Mayo Clin Proc; 2020 Oct; 95(10):2090-2098. PubMed ID: 32829908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Mortality Rates Among Patients With Non-Traumatic Intracerebral Hemorrhage and Atrial Fibrillation on Antithrombotic Therapy Are Independent of the Presence of Cerebral Amyloid Angiopathy: Insights From a Population-Based Study.
    Ponamgi SP; Ward R; DeSimone CV; English S; Hodge DO; Slusser JP; Graff-Radford J; Rabinstein AA; Asirvatham SJ; Holmes D
    J Am Heart Assoc; 2020 Aug; 9(15):e016893. PubMed ID: 32715895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of the CHA
    Jaakkola S; Kiviniemi TO; Nuotio I; Hartikainen J; Mustonen P; Palomäki A; Jaakkola J; Ylitalo A; Hartikainen P; Airaksinen KEJ
    Am J Cardiol; 2018 May; 121(10):1182-1186. PubMed ID: 29526276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the CHA
    Yao X; Gersh BJ; Sangaralingham LR; Kent DM; Shah ND; Abraham NS; Noseworthy PA
    Am J Cardiol; 2017 Nov; 120(9):1549-1556. PubMed ID: 28844514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
    Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation.
    Cannistraro RJ; Meschia JF
    Curr Cardiol Rep; 2018 Sep; 20(11):106. PubMed ID: 30209626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation.
    Chan PH; Huang D; Hai JJ; Li WH; Yin LX; Chan EW; Wong IC; Lau CP; Chiang CE; Zhu J; Tse HF; Siu CW
    Heart Rhythm; 2016 Feb; 13(2):366-73. PubMed ID: 26392326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort.
    Schrag M; Mac Grory B; Nackenoff A; Eaton J; Mistry E; Kirshner H; Yaghi S; Ellis CR
    Transl Stroke Res; 2021 Apr; 12(2):259-265. PubMed ID: 32770310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of HAS-BLED and HAS-BED Versus CHADS
    Poli D; Antonucci E; Pengo V; Testa S; Palareti G
    Am J Cardiol; 2017 Apr; 119(7):1012-1016. PubMed ID: 28237286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Follow-Up of Cerebral Amyloid Angiopathy-Associated Intracranial Hemorrhage Reveals a High Prevalence of Atrial Fibrillation.
    Kaiser J; Schebesch KM; Brawanski A; Linker RA; Schlachetzki F; Wagner A
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104342. PubMed ID: 31521517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic assessment of CHA
    Serna MJ; Rivera-Caravaca JM; López-Gálvez R; Soler-Espejo E; Lip GYH; Marín F; Roldán V
    Rev Esp Cardiol (Engl Ed); 2024 Oct; 77(10):835-842. PubMed ID: 38460882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
    Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
    Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Gao X; Cai X; Yang Y; Zhou Y; Zhu W
    Front Cardiovasc Med; 2021; 8():757087. PubMed ID: 34881309
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
    Lip GYH; Banerjee A; Boriani G; Chiang CE; Fargo R; Freedman B; Lane DA; Ruff CT; Turakhia M; Werring D; Patel S; Moores L
    Chest; 2018 Nov; 154(5):1121-1201. PubMed ID: 30144419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHA
    Carr BW; Wooster ME; Nemani LA; Severance SE; Hartwell JL
    Am J Emerg Med; 2022 Jan; 51():119-123. PubMed ID: 34735969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians' Decision and CHA2DS2-VASc and HAS-BLED Scores.
    Balaghi-Inalou M; Parsa SA; Gachkar L; Andalib S
    High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):61-64. PubMed ID: 29076078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Prediction of the CHA
    Morrone D; Kroep S; Ricci F; Renda G; Patti G; Kirchhof P; Chuang LH; van Hout B; De Caterina R
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
    Apostolakis S; Lane DA; Buller H; Lip GY
    Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.